CytoVale

CytoVale is a company that operates in the field of biotechnology, specializing in the development of diagnostic tools that leverage machine learning and deformability cytometry. The company's primary objective is to provide faster and more accurate detection of diseases, primarily sepsis, which is a major challenge in clinical settings. CytoVale's diagnostic system aims to detect sepsis in less than 10 minutes, a significant improvement over traditional methods, enhancing the efficiency of healthcare providers and potentially saving lives.

Founded in 2013 and based in San Francisco, CytoVale has also extended its technology to detect other diseases. Its diagnostic platform utilizes the science of cell mechanics, coupled with advanced imaging and machine learning, to deliver rapid results. By focusing on the physical properties of cells, CytoVale's technology aims to provide a different perspective in diagnostic approaches. CytoVale underscores the importance of fast, accurate diagnostics in healthcare and strives to deliver practical solutions to meet this critical need.